Colorimetric and Photothermal Dual-Modal Switching Lateral Flow Immunoassay Based on a Forced Dispersion Prussian Blue Nanocomposite for the Sensitive Detection of Prostate-Specific Antigen-Reference-Cited by-同舟云学术

Colorimetric and Photothermal Dual-Modal Switching Lateral Flow Immunoassay Based on a Forced Dispersion Prussian Blue Nanocomposite for the Sensitive Detection of Prostate-Specific Antigen

Published:2024-05-09 Issue:21 Volume:96 Page:8665-8673
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Gong Haijiang¹,Gai Shili¹²^ORCID,Tao Yuelin¹,Du Yaqian¹,Wang Qingyu¹,Ansari Anees Ahmad³^ORCID,Ding He¹,Wang Qingqing¹,Yang Piaoping¹²^ORCID

Affiliation:

1. Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China

2. Yantai Research Institute, Harbin Engineering University, Yantai, 264000, P. R. China

3. College of Science, King Saud University, 11451 Riyadh, Saudi Arabia

Funder

Natural Science Foundation of Heilongjiang Province

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.4c00862

Reference59 articles.

1. Cancer Statistics, 2021

2. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

3. Prostate-Cancer Mortality at 11 Years of Follow-up

4. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics

5. Single-atom Pt-anchored Zn0.5Cd0.5S boosted photoelectrochemical immunoassay of prostate-specific antigen

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review;Nano Today;2024-08